Abstract
The Cost-Effectiveness of Recombinant Human Thyroid Stimulating Hormone Administration Prior to Remnant Ablation for Treatment of Differentiated Thyroid Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have